Zobrazeno 1 - 10
of 22
pro vyhledávání: '"C. Mutebi"'
Autor:
L.E. Ellington, I. Najjingo, J.W. Stout, J. Nakatumba-Nabende, C. Mutebi, J. Edelson, S. Farquhar, B.J. Weiner, G. John-Stewart, M. Rosenfeld, R. Nantanda
Publikováno v:
C25. OPPORTUNITIES AND ADVANCES IN PEDIATRIC GLOBAL HEALTH.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::368b205f116be6befee773b1256f5c25
https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4634
https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4634
Autor:
Shahin Sayed, Anthony K Ngugi, Nicole Nwosu, Miriam C Mutebi, Powell Ochieng, Aruyaru S Mwenda, Rehana A Salam
Publikováno v:
Cochrane Database of Systematic Reviews. 2023
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c38d69bdc1ff4f44e14b55b1c42ea1b
https://doi.org/10.1002/14651858.cd012515.pub2
https://doi.org/10.1002/14651858.cd012515.pub2
Autor:
Samer S. Najjar, H. Kong, U. Fideli, Alfiya Bikineyeva, Steven Hsu, Gerald J. Berry, Charles C. Marboe, Ilker Tunc, Kai Yu, Yanqin Yang, K. Bhatti, Maria E. Rodrigo, Mehdi Pirooznia, Erika D. Feller, Hannah A. Valantine, Stuart D. Russell, Moon Kyoo Jang, Palak Shah, Sean Agbor-Enoh, A. Marishta, Keyur B. Shah, C. Mutebi
Publikováno v:
Circulation
Background: After heart transplantation, endomyocardial biopsy (EMBx) is used to monitor for acute rejection (AR). Unfortunately, EMBx is invasive, and its conventional histological interpretation has limitations. This is a validation study to assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d1f734f916319bf1df7f50a1a1887ab
https://europepmc.org/articles/PMC8221834/
https://europepmc.org/articles/PMC8221834/
Autor:
C. Marboe, I. Ponor, Gerald J. Berry, Steven D. Nathan, Pali D. Shah, Ilker Tunc, Anne Brown, Jonathan B. Orens, Aldo Iacono, Michael Keller, C. Mutebi, Mary Carmelle Philogene, Sean Agbor-Enoh, Kai Yu, I. Timofte, Moon Kyoo Jang, H. Kong
Publikováno v:
J Heart Lung Transplant
BACKGROUND: Acute rejection, which includes antibody-mediated rejection and acute cellular rejection, is a risk factor for lung allograft loss. Lung transplant patients often undergo surveillance transbronchial biopsies to detect and treat acute reje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c17e27fdd431430d3b81db477452c813
https://pubmed.ncbi.nlm.nih.gov/34130911
https://pubmed.ncbi.nlm.nih.gov/34130911
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A. Varghese, R. Woodward, Deborah Levine, C. Mutebi, Pali D. Shah, Michael Keller, Sean Agbor-Enoh, I. Timofte, B. Dale, Shambhu Aryal, J. Mathew, David J. Ross, C. Giner
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S338-S339
Purpose Prior studies have demonstrated that percentage donor-derived cell-free DNA (%dd-cfDNA) in lung transplant patients may serve as a noninvasive marker of allograft injury and aid in the detection of acute allograft rejection, infection and chr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::630bc8cfcb5fe5d1096a7adddcc0d21b
https://doi.org/10.1016/j.healun.2021.01.953
https://doi.org/10.1016/j.healun.2021.01.953
Autor:
C. Marboe, J. Matthews, Anne Brown, A. Charya, Junfeng Sun, Sean Agbor-Enoh, Helen Luikart, G. Berry, J.B. Orens, Aldo Iacono, H. Kong, C. Mutebi, Palak Shah, H.A. Valantine, Ilker Tunc, Moon Kyoo Jang, Steven D. Nathan, Kiran K. Khush
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S157-S158
Purpose Maintenance of immunosuppression in lung transplant recipients (LTx) is integral for preventing allograft rejection, with tacrolimus as a mainstay drug. Prior research from our group showed significantly poorer outcomes for Non-European Ances
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00b8f1a499fde230a70729da781cb07f
https://doi.org/10.1016/j.healun.2021.01.474
https://doi.org/10.1016/j.healun.2021.01.474
Autor:
David J. Ross, R. Woodward, Pali D. Shah, C. Giner, C. Mutebi, Shambhu Aryal, Michael Keller, Sean Agbor-Enoh, I. Timofte, Deborah Levine, B. Dale, J. Mathew, A. Varghese
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S148
Purpose Prior observational data suggest that donor-derived cell-free DNA (dd-cfDNA) increases in lung transplant acute rejection and infection. The performance of dd-cfDNA in routine clinical care remains undefined. In response to the COVID-19 pande
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::304dc556aa7771f3222d2d9af73d2c42
https://doi.org/10.1016/j.healun.2021.01.451
https://doi.org/10.1016/j.healun.2021.01.451
Autor:
Aldo Iacono, H.A. Valantine, Helen Luikart, Kiran K. Khush, Sean Agbor-Enoh, Ilker Tunc, Steven D. Nathan, C. Marboe, A. Charya, Pali D. Shah, Moon Kyoo Jang, Anne Brown, G. Berry, C. Mutebi, J.B. Orens, H. Kong, J. Matthews
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S62
Purpose Tacrolimus is a primary immunosuppressive drug used in lung transplantation (LTx). Unfortunately, significant variability in drug level monitoring and dosing makes it challenging to determine immunosuppression adequacy. Furthermore, the relat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2eb8a86bf82ed032ea0001b56af2161
https://doi.org/10.1016/j.healun.2021.01.1891
https://doi.org/10.1016/j.healun.2021.01.1891
Autor:
C. Mutebi, Aldo Iacono, H.A. Valantine, A. Cochrane, Deborah Levine, L. Ponor, J. Mathew, S. Nathan, Sean Agbor-Enoh, Anne Brown, Kiran K. Khush, G. Berry, J.B. Orens, H. Kong, Moon Kyoo Jang, Charles C. Marboe, Pali D. Shah, Helen Luikart
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S77
Purpose Patients who fail to respond to initial pulmonary antibody-mediated rejection (AMR) treatment may benefit from second generation therapies. Unfortunately, current approaches identify non-responders late after irreversible allograft loss and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3a038a1d424555e65121d2cefd706e2
https://doi.org/10.1016/j.healun.2021.01.1929
https://doi.org/10.1016/j.healun.2021.01.1929